Bio-Rad Labs (BIO) Misses Q1 EPS by 46c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $368.75 -2.18%
Revenue Growth %: -0.3%
Financial Fact:
Net sales: 516.78M
Today's EPS Names:
ANAB, ANIX, MNY, More
Revenue Growth %: -0.3%
Financial Fact:
Net sales: 516.78M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $3.34, $0.46 worse than the analyst estimate of $3.80. Revenue for the quarter came in at $677 million versus the consensus estimate of $696.08 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Frequency Electronics (FEIM) Tops Q1 EPS by 12c
- UBS Downgrades Ypsomed Holding AG (YPSN:SW) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
